Anti interferon-gamma (IFNγ) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis

Pediatric Rheumatology

Volumn 13, Issue 1, 2015, Pages

  Bracaglia, C ^a   Gatto, A ^a   Pardeo, M ^a   Lapeyre, G ^b   Ferlin, W ^b   Nelson, R ^b   de Min, C ^b   De Benedetti, F ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b NOVIMMUNE SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CXCL9 CHEMOKINE; CYCLOSPORIN A; DEXAMETHASONE; FERRITIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY NI 0501; PREDNISONE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; COMPASSIONATE USE; CYTOKINE PRODUCTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; FEVER; GENE; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; INFANT; INTENSIVE CARE UNIT; MISSENSE MUTATION; MULTIPLE ORGAN FAILURE; MUTATIONAL ANALYSIS; NLRC4 GENE; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RASH; SEPSIS; SEVERE HEPATIC IMPAIRMENT; TREATMENT DURATION;

EID: 84956757428     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-13-S1-O68     Document Type: Article

References (0)